In vivo comparison of tantalum, tungsten, and bismuth enteric contrast agents to complement intravenous iodine for double‐contrast dual‐energy CT of the bowel
Open Access
- 18 February 2016
- journal article
- research article
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 11 (4) , 254-261
Abstract
To assess the ability of dual‐energy CT (DECT) to separate intravenous contrast of bowel wall from intraluminal contrast, we scanned 16 rabbits on a clinical DECT scanner: n = 3 using only iodinated intravenous contrast, and n = 13 double‐contrast enhanced scans using iodinated intravenous contrast and experimental enteric non‐iodinated contrast agents in the bowel lumen (five bismuth, four tungsten, and four tantalum based). Representative image pairs from conventional CT images and DECT iodine density maps of small bowel (116 pairs from 232 images) were viewed by four abdominal imaging attending radiologists to independently score each comparison pair on a visual analog scale (−100 to +100%) for (1) preference in small bowel wall visualization and (2) preference in completeness of intraluminal enteric contrast subtraction. Median small bowel wall visualization was scored 39 and 42 percentage points (95% CI 30–44% and 36–45%, both p < 0.001) higher for double‐contrast DECT than for conventional CT with enteric tungsten and tantalum contrast, respectively. Median small bowel wall visualization for double‐contrast DECT was scored 29 and 35 percentage points (95% CI 20–35% and 33–39%, both p < 0.001) higher with enteric tungsten and tantalum, respectively, than with bismuth contrast. Median completeness of intraluminal enteric contrast subtraction in double‐contrast DECT iodine density maps was scored 28 and 29 percentage points (95% CI 15–31% and 28–33%, both p < 0.001) higher with enteric tungsten and tantalum, respectively, than with bismuth contrast. Results suggest that in vivo double‐contrast DECT with iodinated intravenous and either tantalum‐ or tungsten‐based enteric contrast provides better visualization of small bowel than conventional CT. Copyright © 2016 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering T32 (1 T32 EB001631)
- National Institutes of Health (R21EB013816, 1R01EB015476, R01CA122257)
- NIH (R01EB015476)
This publication has 29 references indexed in Scilit:
- Biological Performance of a Size-Fractionated Core-Shell Tantalum Oxide Nanoparticle X-Ray Contrast AgentInvestigative Radiology, 2012
- Large-Scale Synthesis of Bioinert Tantalum Oxide Nanoparticles for X-ray Computed Tomography Imaging and Bimodal Image-Guided Sentinel Lymph Node MappingJournal of the American Chemical Society, 2011
- Computed Tomography in Color: NanoK‐Enhanced Spectral CT Molecular ImagingAngewandte Chemie International Edition, 2010
- Synthesis, characterization, and computed tomography imaging of a tantalum oxidenanoparticle imaging agentChemical Communications, 2010
- Detecting Vascular Biosignatures with a Colloidal, Radio-Opaque Polymeric NanoparticleJournal of the American Chemical Society, 2009
- A review of tungsten: From environmental obscurity to scrutinyJournal of Hazardous Materials, 2006
- An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticlesNature Materials, 2006
- Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysisGut, 2005
- CT evaluation of Crohn's disease: effect on patient managementAmerican Journal of Roentgenology, 1987
- A Feasibility Study of Splenohepatography with Tantalum Metal and Tantalum PentoxideRadiology, 1972